Pérez-Llorca, alongside Gibson, Dunn & Crutcher LLP, advised Elliott Investment Management on the acquisition of Syneos Health, a leading fully integrated biopharmaceutical solutions organisation.
The company was acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital and Veritas Capital. The deal was valued at approximately $7.1 billion, including outstanding debt.
As part of Elliott Investment Management’s business is conducted in Spain, Gibson, Dunn & Crutcher LLP requested Pérez-Llorca’s M&A and Employment assistance and to represent these funds in obtaining FDI approval for the transaction.
The Pérez-Llorca team consisted of partners (picured from left to right) Pablo Figueroa, Francisco Iso and Isabel Moya. It included the support of counsel Alfredo Aguilera, and lawyers Jorge Vellido, Andrea Sánchez, Alejandra González-Concheiro, Jaime Fernández-Durán, and legal advisors Julia Böhme, Bárbara Gómez and Pablo Cano. From Gibson Dunn, partner Attila Borsos led on the global antitrust and FDI clearances for the transaction.